Developing a tool to identify epitopes for drug therapy using semi-supervised and supervised machine learning

The COVID-19 pandemic has been caused by a novel coronavirus, SARS-CoV-2. Viral infections cause the human immune system to respond in two ways: a fast, non-specific response, and a slow response that produces antibodies that will target the infecting virus. Each antibody will recognize a small segment of the virus, called an epitope. If the […]

Read More